Skip to main content
FinSpry Logo
FinSpry
MLYS logo
MLYS
(NASDAQ)
Mineralys Therapeutics, Inc.
$26.34-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Mineralys Therapeutics, Inc. (MLYS) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Mineralys Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$50.40
↑ 91.34% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest MLYS Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Richard Law CFA
Goldman Sachs
BuyMaintains
$49.00 → $42.00
Rami Katkhuda
LifeSci Capital
BuyReiterates
$44.00 → $54.00
Matthew Caufield
HC Wainwright
BuyReiterates
$56.00
Seamus Fernandez
Guggenheim
BuyMaintains
$48.00
Annabel Samimy
Stifel Nicolaus
BuyMaintains
$52.00
Tara Bancroft
TD Cowen
BuyMaintains
-
Jason Gerberry
BofA Securities
BuyMaintains
-
Tara Bancroft
TD Cowen
BuyMaintains
-
Tara Bancroft
TD Cowen
Strong BuyInitiates
-

Frequently Asked Questions

What is the analyst consensus rating for MLYS?

The analyst consensus rating for MLYS is "Buy" based on 7 analyst recommendations.

What is the average price target for MLYS?

The average 12-month price target for MLYS is $50.40, representing an upside of 91.3% from the current price of $26.34.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.